节点文献

磷酸化细胞外信号调节激酶1/2和基质金属蛋白酶-9在宫颈鳞状细胞癌癌变过程中的表达及相关性

Expressions of Clinical Significances of P-Extracellular Regulated Kinase 1/2 and Matrix Metalloproteinase-9 in Cervical Squamous Cell Carcinoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 安风仙王晓刘雯高彦丽马金龙徐兴欣陈世明杨敏

【Author】 AN Feng-xian1,WANG Xiao2,LIU Wen3,GAO Yan-li1,MA Jin-long1,3, XU Xing-xin1,CHEN Shi-ming4,YANG Min4 1Department of Pathology,Provincial Hospital Affiliated to Shandong University,Jinan 250012,China 2Department of Pathology,School of Medicine,Shandong University,Jinan 250012,China 3Shandong Provincial Key Laboratory of Reproductive Medicine,Center for Reproductive Medicine, Provincial Hospital Affiliated to Shandong University,Jinan 250021,China 4Department of Pathology,Qilu Hospital of Shandong University,Jinan 250012,China

【机构】 山东大学附属省立医院病理科山东大学医学院病理学研究所山东大学附属省立医院生殖医学中心山东省生殖医学重点实验室山东大学齐鲁医院病理科

【摘要】 目的探讨宫颈鳞状细胞癌中磷酸化细胞外信号调节激酶(P-ERK)1/2和基质金属蛋白酶(MMP)-9的表达与临床病理关系。方法采用免疫组织化学方法检测P-ERK1/2和MMP-9在30例慢性宫颈炎、45例宫颈上皮内瘤变(CIN)和58例宫颈鳞癌患者组织中的定性表达情况。结果 P-ERK1/2和MMP-9在慢性宫颈炎、CIN及宫颈鳞癌组织中的阳性率分别为0和0、28.9%和24.4%及77.6%和65.5%,3组间差异均有统计学意义(χ2=54.393,P=0.003;χ2=40.968,P=0.005)。宫颈鳞癌患者中,P-ERK1/2和MMP-9在临床Ⅱ~Ⅲ期组、G3组、有淋巴结转移组和肿瘤直径>4 cm组的阳性率分别明显高于临床Ⅰ期组(P=0.015,P=0.002)、G1~G2组(P=0.013,P=0.017)、无淋巴结转移组(P=0.017,P=0.021)和肿瘤直径≤4cm组(P=0.008,P=0.004)。P-ERK1/2与MMP-9在宫颈鳞癌组织中的阳性表达呈正相关(χ2=8.955,P=0.006)。结论 P-ERK1/2和MMP-9的阳性率随宫颈病理改变的程度加深而增加。P-ERK1/2和MMP-9在宫颈鳞癌中过表达可能促进了宫颈鳞癌的浸润及其淋巴结转移,二者在宫颈鳞癌浸润转移过程中可能有协同作用。

【Abstract】 Objective To study the expressions and clinical significances of p-extracellular regulated kinase(P-ERK)1/2 and matrix metalloproteinase-9(MMP-9)in cervical squamous cell carcinoma.Methods The expressions of P-ERK1/2 and MMP-9 in 30 cases with chronic cervicitis,45 cases with cervical intraepithelial neoplasia(CIN),and 58 cases with cervical squamous cell carcinoma were detected by immunohistochemical method.Results The positive rates of P-ERK1/2 and MMP-9 in chronic cervicitis,CIN,and cervical squamous cell carcinoma were 0 and 0,28.9% and 24.4%,77.6% and 65.5%,respectively,showing significant differences among these three groups(χ2 = 54.393,P=0.003;χ2=40.968,P=0.005).The positive rates of P-ERK1/2 and MMP-9 in patients at clinical stages Ⅱ-Ⅲ,at G3,with lymphatic metastasis,or with a tumor diameter greater than 4 cm were significantly higher than those at clinical stage Ⅰ(P=0.015,P=0.002),at G1-G2(P=0.013,P=0.017),without lymphatic metastasis(P=0.017,P=0.021),or with a tumor diameter less or equal than 4 cm in cervical squamous cell carcinoma(P=0.008,P=0.004).There was a positive correlation between P-ERK1/2 and MMP-9 in cervical squamous cell carcinoma(χ2=8.955,P=0.006).Conclusions The expressions of P-ERK1/2 and MMP-9 increase gradually with the progression of cervical squamous cell carcinoma.The overexpressions of P-ERK1/2 and MMP-9 may promote the infiltration of cervical squamous cell carcinoma and lymphatic metastasis,druing which these two enzymes may exert their effets in a synergistic manner.

  • 【文献出处】 中国医学科学院学报 ,Acta Academiae Medicinae Sinicae , 编辑部邮箱 ,2012年06期
  • 【分类号】R737.33
  • 【被引频次】7
  • 【下载频次】87
节点文献中: